---
title: "INTS.US (INTS.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/INTS.US/news.md"
symbol: "INTS.US"
name: "INTS.US"
parent: "https://longbridge.com/zh-CN/quote/INTS.US.md"
datetime: "2026-03-14T05:24:07.820Z"
locales:
  - [en](https://longbridge.com/en/quote/INTS.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/INTS.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/INTS.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/INTS.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/INTS.US/news.md)


# INTS.US (INTS.US) — 相关新闻

### [Intensity Therapeutics Updates Breast Cancer Trial, Files To Resume Enrollment Following Study Pause](https://longbridge.com/zh-CN/news/278911339.md)
*2026-03-12T15:15:08.000Z*
> Intensity Therapeutics Inc. (NASDAQ:INTS) has updated its INVINCIBLE-4 Study on INT230-6 for triple-negative breast canc

### [BUZZ-Intensity Therapeutics rises as breast cancer drug shows early promise](https://longbridge.com/zh-CN/news/278875442.md)
*2026-03-12T11:40:10.000Z*
### [Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study | INTS Stock News](https://longbridge.com/zh-CN/news/278874097.md)
*2026-03-12T03:30:55.000Z*
> Intensity Therapeutics, Inc. Provides Update on the Phase 2 Presurgical Triple-Negative Breast Cancer INVINCIBLE-4 Study

### [Intensity Therapeutics Regains Compliance with Nasdaq's Minimum Bid Price Requirement | INTS Stock News](https://longbridge.com/zh-CN/news/278100894.md)
*2026-03-06T04:47:00.000Z*
> Intensity Therapeutics, Inc. has regained compliance with Nasdaq's minimum bid price requirement, confirming that its st